Suppr超能文献

[老年患者动脉高血压和心房颤动的药物治疗:有哪些新见解和建议?]

[Drug therapy for arterial hypertension and atrial fibrillation in frail patients : Are there any new insights and recommendations?].

作者信息

Müller-Werdan Ursula

机构信息

Medizinische Klinik für Geriatrie und Altersmedizin, Charité - Universitätsmedizin Berlin, Reinickendorfer Str. 61, 13347, Berlin, Deutschland.

Evangelisches Geriatriezentrum Berlin, Reinickendorfer Str. 61, 13347, Berlin, Deutschland.

出版信息

Inn Med (Heidelb). 2024 May;65(5):517-523. doi: 10.1007/s00108-024-01681-8. Epub 2024 Mar 8.

Abstract

The frail and elderly are considered to be at particular risk of suffering an adverse drug reaction. Empirical studies confirm the increased rate of adverse drug reactions. Whether frailty per se impairs drug metabolism or the underlying organ ageing processes and multimorbidity cannot be answered with certainty based on current data. Cardiovascular diseases exhibit a considerable interdependence with frailty. For example, there is a disproportionate syndromal interdependence between heart failure and frailty, and the typical ageing processes of the sinus node can be interpreted as heartbeat frailty. Multimorbidity in the elderly often includes a cluster of chronic cardiovascular diseases, often leading to the use of several cardiovascular medications as required. More recent definitions of polypharmacy assess the appropriateness of drugs rather than their number. The Fit-fOR-The-Aged (FORTA) list, the PRISCUS 2.0 list and the "Cochrane Library Special Collection on deprescribing", for example, offer a practice-oriented assessment aid. In the treatment of arterial hypertension, the target values for older people have also been set ever lower in recent years. In the case of frail elderly people, on the other hand, the guidelines do not specify a strict blood pressure target corridor; tolerability is the crucial factor here. When initiating antihypertensive therapy in frail individuals, one can consider monotherapy-in a departure from the standard case of dual combination therapy. The OPTIMISE study showed that discontinuation of one blood pressure medication did not lead to better tolerability of the drug therapy. Current studies come to differing conclusions regarding the risk-benefit assessment of new oral anticoagulants compared to vitamin K antagonists in the anticoagulation of frail elderly people with atrial fibrillation. Shared decision-making, which could improve adherence particularly in older people, is recommended.

摘要

体弱老年人被认为特别容易发生药物不良反应。实证研究证实了药物不良反应发生率的增加。基于目前的数据,尚无法确定体弱本身是否会损害药物代谢,还是潜在的器官衰老过程和多种疾病并存导致的。心血管疾病与体弱之间存在相当大的相互依存关系。例如,心力衰竭和体弱之间存在不成比例的综合征相互依存关系,窦房结的典型衰老过程可被解释为心跳衰弱。老年人的多种疾病并存往往包括一系列慢性心血管疾病,常常需要根据需要使用多种心血管药物。最近对多重用药的定义评估的是药物的适当性而非其数量。例如,“适合老年人的药物”(FORTA)清单、PRISCUS 2.0清单以及“Cochrane图书馆关于减药的特别专辑”提供了一种以实践为导向的评估辅助工具。近年来,在动脉高血压的治疗中,老年人的目标值也被设定得越来越低。另一方面,对于体弱的老年人,指南并未规定严格的血压目标范围;耐受性是这里的关键因素。在体弱个体中开始抗高血压治疗时,可以考虑采用单药治疗——这与标准的联合治疗情况不同。OPTIMISE研究表明,停用一种血压药物并不会提高药物治疗的耐受性。目前的研究对于新型口服抗凝剂与维生素K拮抗剂相比,在体弱房颤老年人抗凝治疗中的风险效益评估得出了不同结论。建议采用共同决策,这尤其有助于提高老年人的依从性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验